Citius Oncology, Inc.
CTOR
$0.75+0.81%
End of day · as of Aug 25, 2026, 9:16 AM ET
Mkt cap
$105.18M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$1.49M
EPS (9mo ended 2026-06-30)
$-0.42
Gross Margin (qtr ended 2026-06-30)
67.07%
Profit Margin (qtr ended 2026-06-30)
-597.40%
Beta
-0.06
Div yield
N/A
Sector
Healthcare
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CTOR revenue for 2026-06-30 was $1.5M. Net income was -$8.9M. Revenue was down 10.4% from 2026-03-31 to 2026-06-30. CTOR currently screens at market cap $105.2M.
Use this CTOR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CTOR income, balance, and cash tables.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Citius Oncology, Inc. (CTOR) revenue for Jun 30, 2026 was $1.5M. Net income was -$8.9M. Statements: https://lician.com/financials/ctor
Citius Oncology, Inc. (CTOR) market capitalization is $105.2M on the latest cached snapshot.
Citius Oncology, Inc. (CTOR) cached previous close $0.74; day range $0.72 – $0.76; volume 16,521. Session quote: https://lician.com/quote/ctor
Citius Oncology, Inc. (CTOR) latest cached earnings event is "CTOR earnings" on Aug 18, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CTOR filing is 8-K · Sep 29, 2026. Filings: https://lician.com/sec/ctor